JV is devoted to the development and production of biosimilars, compounds close in structure to a biologic, which is made from proteins

China will have to turn to dividends from its elderly as its population declines, one expert said, while Hong Kong's stock exchange sees biotech applications as a way to manage an ageing society

Federal officials found Xiang Haitao in possession of copies of a proprietary predictive algorithm as he was waiting to board a flight to China 

The Nasdaq-listed biotechnology firm approached Samsung to sell its shares, which could be valued at more than 50 trillion won ($42 billion)

The fund follows an ethical mandate set by parliament and is not allowed to invest in companies that produce nuclear weapons and tobacco, among other things

Zero or negative interest rates incentivise risky investing and many are putting money into higher-risk asset classes for the first time in pursuit of returns

Data compiled by Enterprise Singapore showed amount raised rose more than five times from the $86 million in 2016 to $464 million last year

In a sector long regarded as a hotbed of mergers and acquisitions, the total value of deals struck this year hit $81 billion, a third lower than 2020

Ractopamine is permitted for use in food producing animals in more than 20 countries, including Australia, the US, Canada and Japan

Shares plunged nearly 20% on Wednesday after a report that Washington was considering blacklisting Chinese biotechnology groups

The study tested antibody levels of 25 recipients of CoronaVac vaccine and found none had sufficient antibodies to neutralise the new strain

Beijing-based biotechnology company develops and commercialises immune-oncology and molecularly-targeted cancer treatment drugs